Clinical Trial Update: Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating hypofractionated chemoradiotherapy with consolidative immunotherapy versus conventional chemoradiotherapy for locally advanced non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Locally Advanced Non-Small Cell Lung Cancer | Phase 3 | Status: RECRUITING